Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Rheumatology
•
General Rheumatology
•
steroids
•
Endocrinology
•
Prednisone
What is your approach to peri-operative stress-dose steroids in patients on chronic prednisone?
Is it indicated and how do you dose them?
Related Questions
What is your approach to tapering chronic steroids in patients who are at high risk of HPA suppression?
Can joint replacement surgery be performed in someone with active Paget’s disease elsewhere?
What is your approach to the management of isolated total hip osteoporosis in a post menopausal woman without fracture history and low FRAX risk (based on their femoral neck osteopenic t score)?
What is your approach to management of methotrexate osteopathy?
What treatment options do you recommend in a patient with idiopathic granulomatous mastitis that has not improved on steroids and methotrexate?
Does hepatitis B vaccination reduce the risk of HBV reactivation associated with immunosuppressive therapy?
How would you approach treatment of glucocorticoid induced osteoporosis in a patient 10 years post renal transplant, egfr > or =35, on chronic prednisone therapy who has completed 10 years of bisphosphonate therapy and whose DEXA continues to be T-score <~2.5?
What is your approach to rheumatologic disease management during the current methotrexate shortage?
How do you manage a patient with severe RA or SLE that worsens after stopping immunosuppressants due to having chronic foot ulceration?
What is your approach to differentiating and managing DMARD-induced nodulosis (induced by methotrexate or leflunomide for example) from "de novo" RA nodules in seropositive RA patients?
